AbbVie Tells 7th Circ. Asserting Rights Isn't 'Patent Thicket'
AbbVie and other pharmaceutical companies are urging the Seventh Circuit to uphold their antitrust win in Humira buyers' suit over the drug's alleged "patent thicket," arguing that the buyers are challenging...To view the full article, register now.
Already a subscriber? Click here to view full article